DEA Gets Behind Call For Stricter Custom Labels
Custom labels are critical to pharmaceutical products. However, many government officials and consumer advocates in high places have decried the state of labels placed on opioid painkillers and called for stricter regulations be applied to labeling such products. Supporters of more stringent measures say current labels are not forceful enough to prevent addiction to painkillers.
Now, the U.S. Drug Enforcement Agency (DEA) has thrown its hat into the ring by sending a letter to the U.S. Food and Drug Administration (FDA) voicing its full support for new regulations that would enhance labeling restrictions in an effort to curb any potential instances of drug abuse.
Language on Custom Label Stickers in Focus
Recently, the FDA held a public hearing on the issue of custom label stickers for opioids, in which it heard the testimony of physicians who prescribe such drugs and others. At issue was the language on labels. Advocates for tighter regulations said the current labeling system, which allows for opioids to be prescribed to treat "moderate to severe" pain, can lead to drug abuse. They suggested "moderate" being entirely cut from labels so that only patients in true need of the high-strength painkillers can use them.